Study of Secutrelvir in Participants With COVID-19

NCT07746544 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1200

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Secutrelvir
DRUG: Placebo

Sponsor

Shionogi